{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:55:43Z","timestamp":1777906543321,"version":"3.51.4"},"reference-count":16,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T00:00:00Z","timestamp":1497830400000},"content-version":"vor","delay-in-days":49,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Psychopharmacology"],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Novel psychoactive substance (NPS) availability is increasing at a phenomenal rate and so is their associated misuse. Currently, the harms associated with NPS misuse are unclear. This report presents the initial findings of a continuing study looking into the impact of NPS misuse on admissions to an acute mental health facility in London. Violence preadmission and violence during admission have been found to be significant in NPS misusers compared to non\u2010NPS substance misusers. Our findings have important consequences for acute mental health, emergency, and public health services. NPS misusers require specific assessment and risk management to reduce the risk of violence towards others.<\/jats:p>","DOI":"10.1002\/hup.2606","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T03:22:19Z","timestamp":1497928939000},"source":"Crossref","is-referenced-by-count":29,"title":["The risk of violence associated with novel psychoactive substance misuse in patients presenting to acute mental health services"],"prefix":"10.1002","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9244-9790","authenticated-orcid":false,"given":"Abu","family":"Shafi","sequence":"first","affiliation":[{"name":"Highgate Mental Health Centre Camden and Islington NHS Foundation Trust  London UK"},{"name":"College Lane Campus University of Hertfordshire  Hatfield UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Gallagher","sequence":"additional","affiliation":[{"name":"Highgate Mental Health Centre Camden and Islington NHS Foundation Trust  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Stewart","sequence":"additional","affiliation":[{"name":"Highgate Mental Health Centre Camden and Islington NHS Foundation Trust  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Martinotti","sequence":"additional","affiliation":[{"name":"College Lane Campus University of Hertfordshire  Hatfield UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ornella","family":"Corazza","sequence":"additional","affiliation":[{"name":"College Lane Campus University of Hertfordshire  Hatfield UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,6,19]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1176\/ps.46.3.248"},{"key":"e_1_2_5_3_1","first-page":"229","article-title":"Co\u2010occurring mental and substance use disorders: The neurobiological effects of chronic stress, focus","volume":"5","author":"Brady K. T.","year":"2007","journal-title":"Am Psychiatr Publ"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001504-199605000-00013"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.86.7.973"},{"key":"e_1_2_5_6_1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).Health responses to new psychoactive substances 2016.http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/2812\/TD0216555ENN.pdf(accessed 20th Sep 2016)."},{"key":"e_1_2_5_7_1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)EU early warning system. Alert 8 February 2016.http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/2873\/2016.4528_WEB.pdf(accessed 20th Sep 2016)."},{"key":"e_1_2_5_8_1","article-title":"A systematic review of the effects of novel psychoactive substances \u2018legal highs\u2019 on people with severe mental illness","volume":"1","author":"Gray R.","year":"2016","journal-title":"Journal of Psychiatric and Mental Health Nursing"},{"key":"e_1_2_5_9_1","unstructured":"Home Office.Psychoactive substances bill.http:\/\/www.legislation.gov.uk\/ukpga\/2016\/2\/contents\/enacted\/data.htm(accessed 20 Sep 2016)."},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/815424"},{"key":"e_1_2_5_11_1","unstructured":"Prisons and Probation Ombudsman Independent Investigations.2016Sep 23.http:\/\/www.ppo.gov.uk\/wp\u2010content\/uploads\/2016\/09\/PPO\u2010amends\u2010NPS\u2010prison\u2010death\u2010figure\u2010news\u2010release.pdf. (accessed 10th October 2016)"},{"key":"e_1_2_5_12_1","article-title":"Psychoactive Substances Act 2016\u2010unknown unknowns. E\u2010letter to the editor","author":"Shafi A.","journal-title":"The British Journal of Psychiatry"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009430"},{"key":"e_1_2_5_14_1","first-page":"125","article-title":"Prevalence of substance use disorders in psychiatric patients: A nationwide Danish population\u2010 based study","volume":"51","author":"Toftdahl N. G.","year":"2015","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"key":"e_1_2_5_15_1","unstructured":"United Nations Office on Drugs and Crime (UNODC).Global Smart Update 2016.http:\/\/www.unodc.org\/documents\/scientific\/Global\u2010SMART\u2010Update\u20102016\u2010vol\u201016.pdf(accessed 16 Sep 2016)."},{"key":"e_1_2_5_16_1","unstructured":"UNODC Early Warning Advisory (EWA) on New Psychoactive Substances (NPS)https:\/\/www.unodc.org\/LSS\/Page\/NPS(accessed 16 Sep 2016)."},{"key":"e_1_2_5_17_1","article-title":"Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: A review of case reports and preclinical findings","volume":"28","author":"Zanda M. T.","year":"2016","journal-title":"Behavioural Pharmacology"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.2606","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hup.2606","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T05:12:08Z","timestamp":1696569128000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hup.2606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.1002\/hup.2606"],"URL":"https:\/\/doi.org\/10.1002\/hup.2606","archive":["Portico"],"relation":{},"ISSN":["0885-6222","1099-1077"],"issn-type":[{"value":"0885-6222","type":"print"},{"value":"1099-1077","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5]]},"article-number":"e2606"}}